Acharya B M Reddy College Of Pharmacy

Acharya and B.M. Reddy College of Pharmacy sits at rank 82 in the Ministry of Education's NIRF pharmacy list for 2025. Its own homepage still leads with the rank 57 it held in 2022. Both numbers are real, and the filings behind both are public, so the gap between the two can be read rather than argued about. Those filings describe a college whose NIRF research score has more than doubled since 2022 while the reputation score assessors award it has fallen hard, and a bachelor's cohort that increasingly leaves for further study rather than a salary.

The college occupies a corner of the Acharya Institutes campus at Soldevanahalli, in the northern half of Bengaluru. The Pharmacy Council of India files it there precisely: Soldevanahalli, Bengaluru Urban district, Bengaluru North sub-district, pin code 560107, under the institute identifier PCI-32, in the council's decision letter for the college. The Acharya name is carried by unrelated institutions elsewhere in India, so hold on to the Soldevanahalli campus name when you are comparing offers. Even the two regulators disagree about the address: the technical education council files the same college at pin code 560090, in its own letter.

The college opened in 1992, and its recognitions run wider than the two regulators most applicants check: the Department of Scientific and Industrial Research and the Life Sciences Sector Skill Development Council both recognise it, in the group's pharmacy brochure.

Ownership and status are settled by the technical education regulator. The All India Council for Technical Education records the institution under permanent identifier 1-8898831, names JMJ Education Society as the trust behind it, and classes it as Private-Self Financing in the South-West region, in its extension of approval letter.

No degree awarded here belongs to the college. Every degree course is examined by Rajiv Gandhi University of Health Sciences in Bengaluru, from the bachelor's to the Pharm.D to each master's branch. The diploma answers to somebody else entirely, the Board of Examining Authority for the State of Karnataka, which the council names against D.Pharm and against nothing else in the same letter. That split is worth knowing before you apply, because it decides which state process you enter and who eventually signs your certificate.

One practical consequence of sitting inside a large group campus: the library is not the pharmacy college's own. The Learning Resource Centre that serves it runs to 4,289 square metres over three floors, seats around 500 readers at a time and is built for more than 15,000 students drawn from every Acharya institution, on the college's library page. The pharmacy student body is a small fraction of that number, which cuts both ways: better facilities than a standalone college could fund, and a longer queue for them.

Four levels of pharmacy teaching run here at once, and the council approves each of them separately. The diploma, the four year bachelor's, the six year Pharm.D and its three year post baccalaureate route all carry current approval, alongside seven master's branches, in the same decision letter. Doctoral work is offered in pharmaceutical chemistry, pharmaceutics, pharmacology, pharmaceutical analysis and pharmacy practice, on the college's programmes page.

There is one pharmacy fee at this college that a government publishes, and it happens to be the smallest one on the list. The Karnataka Examinations Authority's first round final seat allotment for Diploma Pharmacy 2025, published on 14 January 2026, seats candidates here under college code U017DP against a course fee of Rs 14,300, in that allotment list.

Nothing equivalent exists for the degrees, and that is not an oversight on our part. The Acharya group maintains a page headed Fee Structure 2025-26 which lists D-Pharm, B-Pharm, Pharm-D and PB-Pharm D in its programme selector and prints no amount against any of them, directing applicants to the admissions team instead, on that page. The oddity is worth stating plainly: the one pharmacy course here whose price the state fixes is the two year diploma, and the four longer and costlier ones, the bachelor's through to the Pharm.D, are the blanks. Any rupee figure you meet against a B.Pharm, Pharm.D or M.Pharm seat at Soldevanahalli is therefore somebody's estimate of an unpublished number, and should be replaced with a written schedule from the admission office before a deposit is paid.

Three different state processes lead into this single college, and which one you enter is decided by the course, not by you.

The bachelor's and the six year Pharm.D go through the undergraduate CET counselling run by the Karnataka Examinations Authority, where the college appears under code B002 and its two courses are listed as BP and PD, in the authority's pharmacy cutoff sheet for CET-2024. The diploma has a separate round of its own, run under a different college code in the authority's Diploma Pharmacy allotment, in the list published on 14 January 2026. Master's applicants and post baccalaureate Pharm.D applicants meet the authority a third time, through the process it runs for M.Pharm and Pharma-D (Post Baccalaureate) courses, on its page for those courses.

The college publishes its own academic floors, and they are not the same for the two undergraduate routes. The bachelor's takes four years, and the published bar is 45 per cent aggregate at 10+2 or an accepted equivalent in physics, chemistry, mathematics and one of biology, zoology or computer science, on its B.Pharm page. The Pharm.D runs six years, five of study followed by one of internship or residency, and admits either a 10+2 pass with physics, chemistry and either mathematics or biology as compulsory subjects or a Diploma in Pharmacy, with the candidate required to have completed 17 years of age on or before 31 December of the admission year, on its Pharm.D page.

The closing ranks at this college run against the intuition most applicants arrive with. In CET-2024 the general merit seat in Pharm.D closed far tighter than the general merit seat in B.Pharm, and then refused to move at all.

Round one of the general allotment closed B.Pharm here at rank 23378 in general merit and Pharm.D at 10352, in the authority's round one sheet. By round two, B.Pharm general merit had slid out to 36640 while Pharm.D general merit sat exactly where it had been, at 10352, in the round two sheet. A bachelor's candidate who missed round one gained a great deal of room by waiting. A Pharm.D candidate gained none.

Category ranks in that second round reverse the general merit picture rather than confirming it. The B.Pharm seat closed at 45522 in 1G, 53988 in 2AG, 47633 in 3AG, 57511 in SCG and 56631 in STG, while the Pharm.D closed at 46154 in 1G, 25801 in 2AG, 25708 in 3AG and 36065 in SCG, in the same round two sheet. Read your own category row rather than the general merit headline, because the two courses reverse their difficulty depending on which one you are counselled under.

Candidates counselled under the Kalyana-Karnataka quota read a different sheet again, and the ranks there are tighter. In round one of CET-2024 this college's B.Pharm closed at 32968 in GMH and 40641 in 2BH, and its Pharm.D at 30858 in 2AH, in the Hyderabad-Karnataka sheet.

For a sense of scale, the state run Government College of Pharmacy in Bengaluru closed its B.Pharm general merit seat at 25626 in that same round two, in the row directly above this college's, in the round two sheet. A rank that lands you here with room to spare would not have reached the government college at all.

A 2025 pharmacy closing rank sheet is not among the documents the authority links from its cut-off ranks page, which for pharmacy stops at the 2017 tables, on that page. Work from the 2024 sheets and budget for movement.

The diploma round is a different world again. The Diploma Pharmacy 2025 first round list records two allotments at this college, both general merit, at ranks 44 and 116, in that allotment list.

Every row below is a whole graduating year group, taken from what the college declares to the Ministry of Education rather than from a selection of its better outcomes.

Read the three bachelor's rows downward and the pattern is hard to miss. The count taking a job has fallen in each of the three years while the count going on to further study has risen sharply, and by 2024-25 more of the cohort had left for another degree than had been placed. The master's rows behave in the opposite direction, placing 53 out of 59 in the same year, in the same sheet. On this college's own returns, then, the B.Pharm here works more often as a step towards a master's than as a job qualification, and the employment record gets materially stronger one degree up.

Every median in that column is a median of placed graduates only. The Rs 5,30,000 on the 2024-25 bachelor's row therefore describes the 42 students who took a job, not the 98 who finished; the other 56 are outside the calculation entirely, which is why a rising median and a falling placement count can sit in the same row without contradicting each other.

The recruiter strip on the college's pages is presented as logos, with no offer numbers and no year attached, so treat a logo as evidence that a company came to campus at some point and nothing more. The bridge from logo to hire is filed somewhere else entirely, in the quality assurance returns rather than on the placements page: a student by student register naming the graduate, the programme, the employer and the pay package in rupees per annum, in that return. It covers 2017-18 to 2021-22 and stops there, so nothing published names a single hire from the years the placements page is selling.

The group's pharmacy brochure states an overall placement rate of 92 per cent, 182 of 198 graduating students, with D.Pharm at 100 per cent and M.Pharm at 99 per cent, and attaches no academic year to any of it, in that brochure. The return filed with the Ministry puts the bachelor's at 42 placed out of 98 for 2024-25, in the data capture sheet. Both documents belong to this college. Only one of them is filed with a regulator.

Sanctioned seats live in the council's approval letter, branch by branch. It approves 100 admissions in B.Pharm, 60 in D.Pharm, 30 in Pharm.D and 10 in Pharm.D (Post Baccalaureate), and splits the master's across seven branches: Pharmaceutics 15, Pharmaceutical Chemistry 15, Pharmacy Practice 15, Pharmacology 15, Pharmaceutical Analysis 9, Pharmaceutical Quality Assurance 9 and Regulatory Affairs 9, in that letter. The same letter approves the closure of M.Pharm Industrial Pharmacy and M.Pharm Pharmacognosy from the 2021-2022 session, so neither is a live option.

Check the master's branch you want against the college before you commit to it. Its own programmes page lists six M.Pharm branches and does not include Pharmacy Practice, on that page, even though the council approves it.

The technical education regulator counts the same master's differently again, setting Pharmaceutics at 18, Pharmacology at 18, Drug Regulatory Affairs at 18, Quality Assurance at 12, Pharmaceutical Analysis at 9 and Pharmaceutical Chemistry at 6 for 2021-22, in its approval letter. Two regulators, one college, two different splits of one degree, and no published reconciliation between them.

The figure the college itself files is a third view again. Its postgraduate two year intake was 81 for 2021-22 and 72 for 2022-23, in its 2024 ranking submission, and has stayed at 72 for 2023-24 and 2024-25, with the bachelor's showing 100 in every year that sheet reports it and the six year Pharm.D 30 in all six columns, in its 2026 data capture sheet.

The number that decides whether a KCET rank can reach this college at all is not the sanctioned intake but the far smaller count the state is handed to allot, and the authority publishes that too. Its B.Pharma and Pharma-D seat availability matrix dated 24 July 2024 gives B002 just 28 B.Pharm seats and 9 Pharm.D seats, of which 8 and 3 respectively are general merit, in that matrix. Set 28 against the 100 the council approves and roughly seven in ten bachelor's places here never entered the CET round. The government college in the row above was handed 54 B.Pharm seats to that same round, almost twice as many, which is the other half of why its closing rank sits so much tighter.

NIRF has placed this college inside its pharmacy list for years, and the line it traces is a fall followed by a partial recovery. In 2022 it carried 44.33 points and 57th place, in that year's pharmacy ranking. Two lists later the score had fallen to 41.35 and the place to 86th, in the 2024 ranking. The most recent list puts it 82nd on 43.74, filed from Bengaluru, Karnataka under the institute identifier IR-P-C-40354, in the current ranking.

Split the 2025 total into its five parameters and the weakness becomes specific instead of general. Research and professional practice, which counts publications, patents and funded projects, reached 11.32, while perception, built from what employers and academics report, came in at 27.10, against 60.91 for teaching and learning resources, 61.43 for graduation outcomes and 70.71 for outreach and inclusivity, in the 2025 ranking. Set those against the same two parameters in 2022, when research scored 5.24 and perception scored 54.29, in that ranking. The research engine has roughly doubled in score while the college's standing in the eyes of its own sector has collapsed.

Ranks in this band are also decided by margins too small to mean much. The college immediately above scored 43.75 and the two immediately below scored 43.54, against this college's 43.74, in the 2025 ranking. One hundredth of a point is what separates 82nd from 81st here, and two hundredths separate it from the pair tied at 83rd. On that arithmetic the rank is a label attached to a rounding difference, and the parameter split above tells an applicant far more than the position does.

Meanwhile the college's front page still advertises "Number 57 Nirf Ranking year 2022" as its ranking headline, on that page. It is a true statement about 2022 and a misleading one about today.

The instrumentation is the part of this campus that is documented rather than asserted. The analytical side lists HPLC, FTIR, a Zetasizer, flash chromatography, HPTLC and UV-visible spectrophotometry among the instruments available for testing drugs and formulations, and the research side is organised into centres for integrated drug discovery, cell biology and proteomics, in vivo screening, and formulation and development, on the college's front page.

Spending backs that up. Capital expenditure on new laboratory equipment ran to Rs 55,58,981 in 2024-25 against Rs 36,78,879 in 2022-23, and the library drew Rs 11,00,422 against Rs 5,71,214 over the same two years, in the college's data capture sheet. Laboratory kit is where the money has gone, which is consistent with a research score that keeps climbing.

Disabled students should read the same return closely. The promise covers most of the campus rather than all of it: lifts or ramps and purpose built toilets are reported in more than 80 per cent of the buildings, with wheelchairs, walking aids and help moving between blocks available on top, in the same sheet.

The teaching roll is filed in full every year, name by name. The college entered 58 faculty members in its 2025 return to the Ministry of Education, in that submission, and its next submission lists the table out to 63 rows, each carrying a designation, a qualification, a joining date and, where it applies, a leaving date, in that sheet.

Those leaving dates are the part worth reading. The same table shows professors who have stayed for decades, including one who joined on 03-10-1994 and another on 05-02-1998, sitting alongside a run of assistant professors recruited in 2024 and 2025 and eleven staff whose leaving dates all fall inside 2025, in the same sheet. Eleven departures from a roll of 63 is close to one teacher in six leaving inside a single year, and almost all of them assistant professors rather than the professors who have been here since the 1990s. The senior core is not going anywhere; the staff most likely to take your first and second year classes are the ones the table shows turning over.

Research output is where this faculty distinguishes itself. For 2024-25 the college reports 15 sponsored research projects worth Rs 96,57,684 and 25 consultancy projects worth Rs 48,35,000, against 16 sponsored projects worth Rs 51,25,600 two years earlier, and it records 16 patents published in the calendar year 2024, in that sheet. Doctoral supervision is thin by comparison: the same sheet counts 1 full time and 8 part time scholars pursuing a Ph.D as of 2024-25.

Funding comes from named public agencies, with SERB, ICMR, AICTE, DBT, MoES, RGUHS and VGST listed among the bodies supporting the college's research, on its front page.

At a glance

Quick facts